Wird geladen...
Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to pancreatic cancer?
BACKGROUNDS/AIMS: Gemcitabine is still one of adjuvant options in chemotherapeutic agent for pancreatic ductal adenocarcinoma (PDAC). Integral membrane transporter protein and intracellular enzymes including human equilibrative nucleoside transporter 1 (hENT1), deoxycytidine kinase (dCK), ribonucleo...
Gespeichert in:
| Veröffentlicht in: | Ann Hepatobiliary Pancreat Surg |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Korean Association of Hepato-Biliary-Pancreatic Surgery
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7271117/ https://ncbi.nlm.nih.gov/pubmed/32457256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2020.24.2.127 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|